Physician profile
Robert J Leber
NPI 1952495483
$8,574.06
in general payments reported to CMS, 2019-2025
16 companies · $498 in 2025
The $498 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,636 · 2020: $2,212 · 2021: $1,270 · 2022: $1,901 · 2023: $1,057 · 2025: $498.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,554.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,120.71 | 2020-2025 | Avvigo Guidance System, General - Therapies, Comet |
| Abbott Laboratories | $1,633.29 | 2019-2025 | Diamondback Coronary |
| Philips North America LLC | $811.73 | 2019-2023 | |
| Medtronic, INC. | $793.68 | 2021-2025 | Hawkone |
| Abiomed | $690.41 | 2019 | |
| Shockwave Medical, INC | $677.27 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $633.75 | 2020-2021 | |
| Cvrx, INC. | $380.66 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $276.66 | 2019-2020 | |
| Medtronic Vascular, INC. | $194.10 | 2019 | |
| Esperion Therapeutics, INC. | $150.00 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $62.29 | 2021 | |
| Cagent Vascular INC | $47.48 | 2023 | Serrantor |
| Bayer Healthcare Pharmaceuticals INC. | $43.47 | 2022 | |
| Kestra Medical Technology Services, INC. | $39.38 | 2025 | Assure Wcd |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $19.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Leber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.